ENTITY
Becton Dickinson and Co

Becton Dickinson and Co (BDX US)

63
Analysis
Health Care • United States
Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
more
•02 Feb 2015 14:48

The Matrix: A Strategist's roving thoughts: Swiss Francs, Europe, Alibaba

Key Call: STILL people are not catching up and/or doing the work on KVP’s high conviction long DollarSwissy call, I know, I know, it’s downright...

Share
bullish•Macroeconomics
•20 Jan 2015 22:51

The IMF's Patience with the ECB Wears Thin

The updated World Economic Outlook reveals that the IMF is (rightly) fed up with the ECB’s timid approach to monetary policy.  Monetary policy in...

Logo
507 Views
Share
•18 Jan 2015 11:04

Never Trust A Swiss Central Banker

Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central...

Share
bullish•Eaton Corp Plc
•02 Feb 2026 09:39

Weekly Update (WDC, AAF, WAT)

On January 26, 2026, Eaton Corp (ETN) announced plans to spin off its Mobility Group — which represents roughly 11% of total revenue — in a tax...

Logo
212 Views
Share
•28 Aug 2025 14:00

Becton Dickinson Fuels Biologics Boom With 70+ GLP-1 Agreements; What Lies Ahead?

Becton, Dickinson and Company (BD) reported its third fiscal quarter results for 2025, highlighting both positive developments and challenges...

Logo
284 Views
Share
x